Oral administration of BAF312, a selective sphingosine-1-phosphate receptor agonist, attenuates sodium retention and hypertension in DOCA-salt-treated mice
Year: 2023
Type: article
Institution: Virginia Commonwealth University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funder: National Institutes of Health
Award: G9000102376
OpenAlex ID: W4377029498
